These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7902178)

  • 1. Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture.
    Hall AS; Bryson SE; Vaughan PF; Ball SG; Balmforth AJ
    Br J Pharmacol; 1993 Oct; 110(2):681-6. PubMed ID: 7902178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture.
    Bryson SE; Drew GM; Hall AS; Ball SG; Balmforth AJ
    Eur J Pharmacol; 1992 Jan; 225(1):1-5. PubMed ID: 1347268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured mesenteric vascular smooth muscle cells express dopamine DA1-receptors.
    Balmforth AJ; Lyall F; Morton JI; Ball SG
    Eur J Pharmacol; 1988 Oct; 155(3):305-8. PubMed ID: 2853067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenoxybenzamine mediated inhibition of the vascular dopamine D1 receptor.
    Hall AS; Bryson SE; Ball SG; Balmforth AJ
    Eur J Pharmacol; 1993 Nov; 247(3):249-55. PubMed ID: 8307098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiol group identification at or near the agonist binding site of the vascular dopamine receptor.
    Hall AS; Errol C; Bryson SE; Ball SG; Balmforth AJ
    Eur J Pharmacol; 1992 Jul; 226(3):253-8. PubMed ID: 1385185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
    Balmforth AJ; Yasunari K; Vaughan PF; Ball SG
    J Neurochem; 1988 Nov; 51(5):1510-5. PubMed ID: 2459312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine DA1 receptors on vascular smooth muscle cells are regulated by glucocorticoid and sodium chloride.
    Yasunari K; Kohno M; Yokokawa K; Horio T; Takeda T
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R628-34. PubMed ID: 8092305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postsynaptic dopamine DA1- and DA2-receptors in jejunal arteries of rabbits.
    Münch G; Raether A; Schöffel E; Illes P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):468-71. PubMed ID: 1720848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopamine receptor agonists on the cAMP content in arteries of the rabbit.
    Zhu L; Zhao RR; Zhang WF
    Sheng Li Xue Bao; 2000 Jun; 52(3):247-51. PubMed ID: 11956574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of the beta-adrenoceptor coupled to cyclic AMP formation, expressed by rat mesenteric artery vascular smooth muscle cells in culture.
    Hall AS; Bryson SE; Ball SG; Balmforth AJ
    J Hypertens Suppl; 1991 Dec; 9(6):S96-7. PubMed ID: 1687879
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.
    Semeraro C; Ferrini R; Allievi L; Pocchiari F; Nicosia S; Casagrande C
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):539-46. PubMed ID: 1982561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
    Grenader A; Healy DP
    Br J Pharmacol; 1992 Jun; 106(2):229-30. PubMed ID: 1356555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between a phorbol ester and dopamine DA1 receptors on vascular smooth muscle.
    Yasunari K; Kohno M; Murakawa K; Yokokawa K; Horio T; Takeda T
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F24-30. PubMed ID: 8381602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular dopamine-I receptors.
    Yasunari K; Kohno M; Yokokawa K; Horio T; Kano H; Takeda T
    Hypertens Res; 1995 Jun; 18 Suppl 1():S29-33. PubMed ID: 8529070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of the dopamine-sensitive adenylate cyclase in cockroach brain: evidence for a distinct dopamine receptor.
    Orr GL; Gole JW; Notman HJ; Downer RG
    Life Sci; 1987 Dec; 41(25):2705-15. PubMed ID: 2892104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles.
    Zeng C; Wang D; Yang Z; Wang Z; Asico LD; Wilcox CS; Eisner GM; Welch WJ; Felder RA; Jose PA
    Hypertension; 2004 Mar; 43(3):673-9. PubMed ID: 14769810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proximal tubule Na(+)-K(+)-ATPase activity requires simultaneous activation of DA1 and DA2 receptors.
    Bertorello A; Aperia A
    Am J Physiol; 1990 Dec; 259(6 Pt 2):F924-8. PubMed ID: 1979719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of l-stepholidine on the peripheral vascular dopamine DA1 and DA2 receptor subtypes].
    Zhang W; Zhi J; Guo W; Zhao R; Jin G
    Yao Xue Xue Bao; 1998 Oct; 33(10):721-6. PubMed ID: 12016922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
    Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
    Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.